Revenue (Quarterly)

Revenue: The sum of all revenue fields included for a company's operating activities.

Fortress Biotech, Inc. (FBIO) had Revenue of $13.14M for the most recently reported fiscal quarter, ending 2025-03-31.

Quarterly Annual

Figures for fiscal quarter ending 2025-03-31

Income Statement Financials
Revenue	$13.14M
Net Income	$-12.71M
Cost of Goods Sold	$4.79M
Gross Profit	$8.35M
Operating Expenses	$35.46M
Operating Income	$-22.32M
Non-Operating Income/Expense	$-2.37M
Pre-Tax Income	$-24.69M
Normalized Pre-Tax Income	$-24.69M
Income after Taxes	$-24.69M
Income from Continuous Operations	$-24.69M
Consolidated Net Income/Loss	$-24.69M
Normalized Income after Taxes	$-24.69M
EBIT	$-22.32M
EBITDA	$-20.35M
Weighted-Average Shares Outstanding (Basic)	26.45M
Weighted-Average Shares Outstanding (Diluted)	26.45M
Earnings per Share (EPS) (Basic)	$-0.48
Earnings per Share (EPS) (Diluted)	$-0.48
Balance Sheet Financials
Current Assets	$126.90M
Property, Plant, and Equipment	$2.80M
Long-Term Assets	$51.17M
Total Assets	$178.07M
Current Liabilities	$73.67M
Long-Term Debt	$56.38M
Long-Term Liabilities	$71.91M
Total Liabilities	$145.59M
Common Equity	$32.48M
Tangible Shareholders Equity	$1.69M
Shareholders Equity	$32.49M
Common Shares Outstanding	29.55M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$-19.56M
Cash Flow from Investing Activities	$1.17M
Cash Flow from Financial Activities	$52.14M
Beginning Cash	$58.81M
End Cash	$92.56M
Increase/Decrease in Cash	$33.74M
Stock-Based Compensation	$6.29M
Common Stock Dividends Paid	$-0.17M
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	1.72
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.63
Debt to Equity Ratio	1.79
Gross Margin	63.54%
Operating Margin	-169.85%
EBIT Margin	-169.85%
EBITDA Margin	--
Pre-Tax Profit Margin	-187.92%
Profit Margin	-96.77%
Free Cash Flow	$-18.40M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.07
Inventory Turnover	0.38
Receiveable Turnover	0.72
Days Sales in Receivables	125.58
Return on Equity	-76.01%
Return on Tangible Equity	-1462.74%
Return on Assets	-13.87%
Return on Investments	-27.78%
Book Value Per Share	$1.10
Free Cash Flow per Share	$-0.70
Operating Cash Flow per Share	$-0.74

Data from Zacks Investment Research, Inc.